102 related articles for article (PubMed ID: 2397000)
1. Pharmacokinetics of prenylamine racemate and enantiomers in man.
Paar WD; Brockmeier D; Hirzebruch M; Schmidt EK; von Unruh GE; Dengler HJ
Arzneimittelforschung; 1990 Jun; 40(6):657-61. PubMed ID: 2397000
[TBL] [Abstract][Full Text] [Related]
2. A gas chromatographic/mass spectrometric assay for prenylamine suitable for pharmacokinetic studies of the racemate and the enantiomers.
Schmidt EK; von Unruh GE; Paar WD; Dengler HJ
Biol Mass Spectrom; 1992 Feb; 21(2):103-8. PubMed ID: 1606181
[TBL] [Abstract][Full Text] [Related]
3. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective metabolism and pharmacokinetics of racemic methylphenobarbital in humans.
Lim WH; Hooper WD
Drug Metab Dispos; 1989; 17(2):212-7. PubMed ID: 2565213
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
6. Single- and multiple-dose pharmacokinetics of R-(-)-and S-(+)-prenylamine in man.
Gietl Y; Spahn H; Knauf H; Mutschler E
Eur J Clin Pharmacol; 1990; 38(6):587-93. PubMed ID: 2373134
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective disposition of R-(-)- and S-(+)-prenylamine in the rat.
Gietl Y; Spahn H; Mutschler E
Arzneimittelforschung; 1989 Aug; 39(8):853-6. PubMed ID: 2818674
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of sotalol enantiomers in humans.
Carr RA; Foster RT; Lewanczuk RZ; Hamilton PG
J Clin Pharmacol; 1992 Dec; 32(12):1105-9. PubMed ID: 1487548
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of clinafloxacin enantiomers in humans.
Humphrey GH; Shapiro MA; Randinitis EJ; Guttendorf RJ; Brodfuehrer JI
J Clin Pharmacol; 1999 Nov; 39(11):1143-50. PubMed ID: 10579144
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective pharmacokinetics of indobufen from tablets and intramuscular injections in man.
Główka FK
Chirality; 2000 Jan; 12(1):38-42. PubMed ID: 10602265
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective pharmacokinetics of ornidazole after intravenous administration of individual enantiomers and the racemate.
Chen Y; Liu XQ; Zhong J; Zhao X; Wang Y; Wang G
Chirality; 2006 Nov; 18(10):799-802. PubMed ID: 16906493
[TBL] [Abstract][Full Text] [Related]
13. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
[TBL] [Abstract][Full Text] [Related]
14. Human pharmacology of the methamphetamine stereoisomers.
Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
[TBL] [Abstract][Full Text] [Related]
15. Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide.
Eriksson T; Björkman S; Roth B; Fyge A; Höglund P
Chirality; 1995; 7(1):44-52. PubMed ID: 7702998
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of reboxetine enantiomers in the dog.
Frigerio E; Benecchi A; Brianceschi G; Pellizzoni C; Poggesi I; Strolin Benedetti M; Dostert P
Chirality; 1997; 9(3):303-6. PubMed ID: 9176997
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteers.
Gumbhir-Shah K; Kellerman DJ; DeGraw S; Koch P; Jusko WJ
J Clin Pharmacol; 1998 Dec; 38(12):1096-106. PubMed ID: 11301561
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of propafenone enantiomers in rats.
Mehvar R
Drug Metab Dispos; 1990; 18(6):987-91. PubMed ID: 1981549
[TBL] [Abstract][Full Text] [Related]
19. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen.
Główka FK; Caldwell J
Chirality; 2002 Oct; 14(9):736-41. PubMed ID: 12237835
[TBL] [Abstract][Full Text] [Related]
20. Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients.
Cerqueira PM; Cesarino EJ; Mateus FH; Mere Y; Santos SR; Lanchote VL
Chirality; 1999; 11(7):591-7. PubMed ID: 10423287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
